IR@PKUHSC  > 北京大学医药卫生分析中心
学科主题公共卫生
Dual-Modality Monitoring of Tumor Response to Cyclophosphamide Therapy in Mice with Bioluminescence Imaging and Small-Animal Positron Emission Tomography
Ma, Xibo; Liu, Zhaofei; Yang, Xin; Gao, Qiujuan; Zhu, Shouping; Qin, Chenghu; Liu, Kai; Zhang, Bo; Han, Dong; Wang, Fan2; Tian, Jie1
刊名MOLECULAR IMAGING
2011-07-01
DOI10.2310/7290.2010.00041
10期:4页:278-283
收录类别SCI
文章类型Article
WOS标题词Science & Technology
类目[WOS]Biochemical Research Methods ; Radiology, Nuclear Medicine & Medical Imaging
研究领域[WOS]Biochemistry & Molecular Biology ; Radiology, Nuclear Medicine & Medical Imaging
关键词[WOS]HEPATOCELLULAR-CARCINOMA ; METASTASIS ; INHIBITION ; GROWTH
英文摘要

The purpose of this study was to noninvasively monitor the therapeutic efficacy of cyclophosphamide (CTX) in a mouse model by dual-modality molecular imaging: positron emission tomography (PET) and bioluminescence imaging (BLI). Firefly luciferase (fLuc) transfected HCC-LM3-fLuc human hepatocellular carcinoma cells were injected subcutaneously into BALB/c nude mice to establish the experimental tumor model. Two groups of HCC-LM3-fLuc tumor-bearing mice (n = 7 per group) were treated with saline or CTX (100 mg/kg on days 0, 2, 5, and 7). BLI and (18)F-fluorodeoxyglucose ((18)F-FDG) PET scans were done to evaluate the treatment efficacy. CTX induced a 25.25 +/- 13.13% and 35.91 +/- 25.85% tumor growth inhibition rate on days 9 and 12 posttreatment, respectively, as determined by BLI. A good linear correlation was found between the tumor sizes measured by caliper and the BLI signals determined by optical imaging (R(2) = .9216). (18)F-FDG imaging revealed a significant uptake reduction in the tumors of the CTX-treated group compared to that in the saline control group (5.30 +/- 1.97 vs 3.00 +/- 2.11% ID/g) on day 16 after CTX treatment. Dual-modality molecular imaging using BLI and small-animal PET can play important roles in the process of chemotherapy and will provide noninvasive and reliable monitoring of the therapeutic response.

语种英语
WOS记录号WOS:000294562600006
引用统计
被引频次:13[WOS]   [WOS记录]     [WOS相关记录]
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/67878
专题北京大学医药卫生分析中心
作者单位1.Chinese Acad Sci, Med Image Proc Grp, Inst Automat, Beijing 100190, Peoples R China
2.Peking Univ, Med Isotopes Res Ctr, Beijing 100191, Peoples R China
3.Northeastern Univ, Sino Dutch Biomed & Informat Engn Sch, Shenyang, Peoples R China
推荐引用方式
GB/T 7714
Ma, Xibo,Liu, Zhaofei,Yang, Xin,et al. Dual-Modality Monitoring of Tumor Response to Cyclophosphamide Therapy in Mice with Bioluminescence Imaging and Small-Animal Positron Emission Tomography[J]. MOLECULAR IMAGING,2011,10(4):278-283.
APA Ma, Xibo.,Liu, Zhaofei.,Yang, Xin.,Gao, Qiujuan.,Zhu, Shouping.,...&Tian, Jie.(2011).Dual-Modality Monitoring of Tumor Response to Cyclophosphamide Therapy in Mice with Bioluminescence Imaging and Small-Animal Positron Emission Tomography.MOLECULAR IMAGING,10(4),278-283.
MLA Ma, Xibo,et al."Dual-Modality Monitoring of Tumor Response to Cyclophosphamide Therapy in Mice with Bioluminescence Imaging and Small-Animal Positron Emission Tomography".MOLECULAR IMAGING 10.4(2011):278-283.
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Ma, Xibo]的文章
[Liu, Zhaofei]的文章
[Yang, Xin]的文章
百度学术
百度学术中相似的文章
[Ma, Xibo]的文章
[Liu, Zhaofei]的文章
[Yang, Xin]的文章
必应学术
必应学术中相似的文章
[Ma, Xibo]的文章
[Liu, Zhaofei]的文章
[Yang, Xin]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。